Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis (Q37531320)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2009

Language	Label	Description	Also known as
English	Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis	scientific article published on July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

0 references

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

20 August 2017

World Health Organization

0 references

0 references

0 references

anti-retroviral agent

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

Alessandro Cozzi-Lepri

4

object named as

Alessandro Cozzi-Lepri

0 references

Charles F. Gilks

object named as

Charles Gilks

9

0 references

6

object named as

Sabine Yerly

1 reference

Europe PubMed Central

20 August 2017

5

object named as

Viktor von Wyl

1 reference

Europe PubMed Central

20 August 2017

10

object named as

Deenan Pillay

1 reference

Europe PubMed Central

20 August 2017

Huldrych F Günthard

8

object named as

Huldrych F Günthard

1 reference

Europe PubMed Central

20 August 2017

author name string

Ravindra K Gupta

1

1 reference

Europe PubMed Central

20 August 2017

Andrew Hill

2

1 reference

Europe PubMed Central

20 August 2017

Anthony W Sawyer

3

1 reference

Europe PubMed Central

20 August 2017

Viviane Dias Lima

7

1 reference

Europe PubMed Central

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2009

1 reference

Europe PubMed Central

20 August 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

20 August 2017

9

1 reference

Europe PubMed Central

20 August 2017

7

1 reference

Europe PubMed Central

20 August 2017

409-417

1 reference

Europe PubMed Central

20 August 2017

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss to follow-up in an international, multicentre observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 viral load assays for resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970136-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(09)70136-7

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37531320&oldid=2112507507"